Former TL1 Scholar Makes the News

May 29, 2020
Chris Cowan, chairman of the Department of Neuroscience, observes Adam Harrington and Catherine Bridges at work. Harrington and Bridges are joint lead authors of a new paper about MEF2C haploinsufficiency syndrome.

 

Former TL1 Scholar Catherine Bridges, an M.D., Ph.D. student at the Medical University of South Carolina, is making the news, and in more than one way.

Bridges, who works in the laboratory of noted neuroscientist and autism researcher Christopher Cowan, Ph.D.,  is co-lead author of a recent Biological Psychiatry article about a rare form of autism called MEF2C haploinsufficiency syndrome. In the article, Bridges, co-lead author Adam Harrington, a postdoctoral scholar, Cowan, and others showed that mutations in the MEF2C gene in a mouse model disrupt DNA binding and result in phenotypes similar to those seen in humans with the disorder. They also investigated which cells in the brain are responsible for these phenotypes. Read more about their work on MUSC Catalyst News and EurekAlert!.

Bridges is well-versed with both news platforms because, as a College of Graduate Studies communications intern, she has written stories about high-impact research, particularly neuroscience research. These include a recent story about a pilot study testing transcranialmagnetic stimulation as a treatment for adults with both autism and depression.

Despite her busy schedule as an M.D., Ph.D. student, Bridges saw the value in helping other MUSC investigators translate their findings for a lay audience.

“I think that's important because science affects the lives of everybody, not only through medicine but also helping us understand how the world works.” -- Catherine Bridges

 

About the Author

Kim McGhee
Science Writer
Ph.D.